Drug search by name

Axicabtagene ciloleucel Intravenous and Hepatitis B reactivation

Result of checking the interaction of drug Axicabtagene ciloleucel Intravenous and disease Hepatitis B reactivation for safety when used together.

Check result:

Axicabtagene ciloleucel Intravenous <> Hepatitis B reactivation

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of drugs directed against B cells, such as axicabtagene ciloleucel, and tisagenlecleucel is associated with hepatitis B reactivation, some cases have resulted in fulminant hepatitis, hepatic failure, and death. Close monitoring is recommended when using these agents in patients with a history of hepatitis infection. It is recommended to screen patients for HBV, HCV, and HIV in accordance with clinical guidelines before collection of cells for manufacturing.

Axicabtagene ciloleucel Intravenous

Generic Name: axicabtagene ciloleucel

Brand Name: Yescarta

Synonyms: Axicabtagene ciloleucel, Axicabtagene Ciloleucel

What is Axicabtagene ciloleucel Intravenous?